Abstract 5552: Novel, heterocyclic small molecule inhibitors of PD-1 and PD-L1 pathway
Dhanalakshmi, Sivanandhan, Garapaty, Shivani, Venkateshappa, Chandregowda, Seerapu, Guru Pavan, Das, Reshma, Nagaraj, Pradeep, Kar, Ronodip, Singh, Anuj Kumar, Venkatesubbiah, Venkatesha Ashokkumar, Putta, Ramakishore VP, Pendyala, Muralidhar, Lokesh, Girisha, Madaka, Hari, Thummuru, Harikrishna Reddy, AP, Shikas, Anchan, Prateeksha, Bhat, Prathima, G, Rudresha, Zainuddin, Mohd, V, Krishnakumar, Gosu, Ramachandraiah, Kristam, Rajendra, DA, Jeyaraj, Rajagopal, Sriram
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract 4432: A highly differentiated A2AR inhibitor for potential use in cancer therapy
Venkateshappa, Chandregowda, Narayanan, Kishore, Nair, Rashmi, AB, Aravind, Putta, Ramakishore VP, Nagaraj, Jwala, Goyal, Megha, Ahuja, Vijay Kamal, Dhudashiya, Amith A, DS, Samiulla, Daginakatte, Girish, Antony, Thomas, Nellore, Kavitha, Samajdar, Susanta, Ramachandra, Murali
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article